Risk factors for grade 3/4 transaminase elevation in patients with chronic lymphocytic leukemia treated with idelalisib.
Jennifer R BrownAndrew ZelenetzRichard FurmanNicole LamannaAnthony MatoMarco MontilloSusan O'BrienRonald DubowyLin GuVeerendra MunugalavadlaTadeusz RobakPeter HillmenPublished in: Leukemia (2020)
Keyphrases